Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2003-7-15
pubmed:abstractText
Because traditional therapies for rheumatoid arthritis (RA) such as methotrexate (MTX) do not produce an adequate response in many patients, newer therapies that block the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) are increasingly being used in combination with MTX.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0149-2918
pubmed:author
pubmed:issnType
Print
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1700-21
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:12860493-Adult, pubmed-meshheading:12860493-Aged, pubmed-meshheading:12860493-Antibodies, Monoclonal, pubmed-meshheading:12860493-Antibodies, Monoclonal, Humanized, pubmed-meshheading:12860493-Antirheumatic Agents, pubmed-meshheading:12860493-Area Under Curve, pubmed-meshheading:12860493-Arthritis, Rheumatoid, pubmed-meshheading:12860493-Dose-Response Relationship, Drug, pubmed-meshheading:12860493-Double-Blind Method, pubmed-meshheading:12860493-Drug Therapy, Combination, pubmed-meshheading:12860493-Female, pubmed-meshheading:12860493-Half-Life, pubmed-meshheading:12860493-Humans, pubmed-meshheading:12860493-Injections, Intravenous, pubmed-meshheading:12860493-Injections, Subcutaneous, pubmed-meshheading:12860493-Male, pubmed-meshheading:12860493-Methotrexate, pubmed-meshheading:12860493-Middle Aged, pubmed-meshheading:12860493-Pilot Projects, pubmed-meshheading:12860493-Treatment Outcome, pubmed-meshheading:12860493-Tumor Necrosis Factor-alpha
pubmed:year
2003
pubmed:articleTitle
Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.
pubmed:affiliation
Cedars-Sinai Medical Center, Los Angeles, California 90048, USA. weisman@cshs.org
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase I